TipRanks
Go Ultimate55% OFF

Karyopharm Therapeutics (KPTI) Balance Sheet

Karyopharm Therapeutics Balance Sheet

Karyopharm Therapeutics's total assets for Q2 2026 were $111.32M, a decrease of 15.29% from the previous quarter. CH:KPTI total liabilities were $441.49M for the fiscal quarter, a 11.19% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 108.42M$ 164.42M$ 240.44M$ 358.17M$ 305.31M
$ 401.34M$ 350.44M$ 376.64M$ 374.83M$ 384.98M
$ -292.93M$ -186.02M$ -136.21M$ -16.66M$ -79.67M

Currency in USD

Karyopharm Therapeutics Debt to Assets

0150M300M450M0 %150 %300 %450 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets